14-day RSI
47.08
-1.20-2.49%
27 November 2024
Summary:
PharmaCyte Biotech stock 14-day relative strength index is 47.08, with the most recent change of -1.20 (-2.49%) on 27 November 2024. According to this value, PMCB stock is neither oversold nor overboughtPMCB RSI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB RSI Performance
PeriodPeriod | 14-day RSI14-day RSI | PricePrice | 50-day SMA50-day SMA | 200-day SMA200-day SMA |
---|---|---|---|---|
todaytoday | -2.5% | -1.2% | -0.3% | -0.1% |
1 m1 month | -10.6% | -5.0% | +1.7% | -2.5% |
3 m3 months | +115.3% | +12.5% | -9.3% | -6.9% |
6 m6 months | -4.7% | -20.1% | -19.9% | -10.6% |
ytdytd | +2.3% | -20.8% | -18.8% | -23.6% |
1 y1 year | -23.2% | -25.6% | -17.4% | -25.9% |
5 y5 years | +1.3% | -96.8% | -96.8% | -96.8% |
PMCB RSI High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | 61.49 | -23.4% | 38.12 | +23.5% |
3 m | 3 months | 66.08 | -28.8% | 21.87 | +115.3% |
6 m | 6 months | 66.08 | -28.8% | 21.87 | +115.3% |
1 y | 1 year | 72.78 | -35.3% | 21.87 | +115.3% |
3 y | 3 years | 81.76 | -42.4% | 20.17 | +133.4% |
5 y | 5 years | 88.29 | -46.7% | 20.17 | +133.4% |
alltime | all time | 90.10 | -47.8% | 0.00 | -100.0% |
PharmaCyte Biotech Stock RSI History
Date | Value |
---|---|
2024 | 47.08(+2.3%) |
2023 | 46.03(-12.7%) |
2022 | 52.73(+16.2%) |
2021 | 45.39(-17.0%) |
2020 | 54.69(+3.3%) |
2019 | 52.94(+162.9%) |
Date | Value |
---|---|
2018 | 20.14(-60.8%) |
2017 | 51.40(-23.3%) |
2016 | 66.98(+282.7%) |
2015 | 17.50(-61.0%) |
2014 | 44.84(+83.7%) |
2013 | 24.41 |
FAQ
- What is PharmaCyte Biotech 14-day relative strength index?
- What is the all time high 14-day RSI for PharmaCyte Biotech?
What is PharmaCyte Biotech 14-day relative strength index?
The current 14-day RSI of PMCB is 47.08
What is the all time high 14-day RSI for PharmaCyte Biotech?
PharmaCyte Biotech all-time high 14-day relative strength index is 90.10